TABLE 4.
Radiologic and Metabolic Best Overall Response
| Patient no. | CT target response | CT nontarget response | RECIST response | PET target response | PET nontarget response | PERCIST response | SUVmax 18F-FDG baseline | SUVmax 18F-FDG follow-up |
|---|---|---|---|---|---|---|---|---|
| 1 | SD | SD | SD | PMR | SMD | PMD | 14.8 | 21.8 (+47%) |
| 2 | PD | SD | PD | PMD | PMD | PMD | 28.6 | 22.3 (−22%) |
| 3 | SD | SD | SD | SMD | SMD | SMD | 6.5 | 4.9 (−25%) |
| 4 | PD | PD | PD | SMD | PMD | PMD | 5.1 | 3.8 (−26%) |
| 5 | PD | PD | PD | SMD | PMD | PMD | 18.9 | 17.2 (−9%) |
| 6 | SD | SD | SD | — | — | — | 6.1 | — |
| 7 | — | — | — | — | — | — | 14.3 | — |
| 8 | SD | PD | PD | PMD | SMD | PMD | 12.5 | 13.3 (+6.4%) |
| 9 | SD | SD | SD | PMR | SMD | PMR | 18 | 10.1 (−44%) |
| DCR (%) | 4/8 (50%) | 2/7 (29%) | ||||||
| ORR (%) | 0/8 (0%) | 1/7 (14%) |
SD = stable disease; PMR = partial metabolic response; SMD = stable metabolic disease; PMD = progressive metabolic disease; PD = progressive disease; DCR = disease control rate; ORR = overall response rate.